Indrayani Biotech Limited

BSE: 526445
Indrayani Biotech Limited - agriculture in Chennai, Tamil Nadu, India. FY 2026 financials & compliance.
CIN L40100TN1992PLC129301 Incorporated 09 March 1992 ROC Chennai HQ Chennai, Tamil Nadu, India
Active Listed - BSE: 526445 Public Limited Company agriculture MSME · Medium
Data last updated
Market Cap
₹62.92 Cr
INDRANIB · BSE
Share Price
₹7.93
-1.61% today
Revenue
₹138 Cr
FY 2025-26 · +5.8% YoY
EBITDA
₹9.63 Cr
Margin 7.0%
Net Profit
₹2.16 Cr
FY 2025-26 · +135.4% YoY
P/E (TTM)
30.7x
P/B 0.5x
Authorised capital
₹65 Cr
Registered with MCA
Paid-up capital
₹45.54 Cr
Issued & subscribed

About Indrayani Biotech Limited

Data last updated:

Indrayani Biotech Limited is a public limited company based in Chennai, Tamil Nadu, India. It operates in the fertilizers and soil enhancers segment of the agriculture sector. It was incorporated on 09 March 1992 and has been in existence for over 34 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN L40100TN1992PLC129301. Its GSTIN is 33AAACI3911M1ZQ (Tamil Nadu). The company holds 2 GST registrations, all of them active. It is a listed company as per MCA records. Its shares are listed on BSE: 526445.

The company has an authorised share capital of ₹65 Cr and a paid-up capital of ₹45.54 Cr. It is led by directors including Kasiraman Sayee Sundar (Managing Director) and Swaminathan Govindarajan (Whole-Time Director).

Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Chennai, Tamil Nadu.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹137.83 Cr, a growth of 5.8% compared to the previous year. For the same year it recorded a net profit of ₹2.16 Cr (net margin 1.6%) and EBITDA of ₹9.63 Cr (EBITDA margin 7%).

The company has about 445 employees on its provident fund (EPFO) records. Its group structure includes 9 subsidiaries.

The company is associated with 1 brand: Indrayani Biotech. As per MCA filings, the company has open charges of ₹23.62 Cr and satisfied charges of ₹1.16 Cr on record. Court records list 26 cases involving the company, including 20 filed by the company and 6 filed against it; 5 cases are pending. The company has 14 deals on record (14 market trades); the latest was in June 2026.

Indrayani Biotech Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-02-0023808). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indrayani.com.

Company details

CIN L40100TN1992PLC129301
Registration Number 129301
Incorporation Date 09 March 1992
ROC Chennai
Listing Status Listed - Listed on BSE (526445)
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TN-02-0023808

CIN history

Indrayani Biotech has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L40100TN1992PLC129301, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L40100TN1992PLC129301Current
L40100PN1992PLC065801Previous
L24231PN1992PLC065801Previous
Key People
Kasiraman Sayee Sundar Managing Director Swaminathan Govindarajan Whole-Time Director Muthukrishnan Ramesh Whole-Time Director

Recognitions & Rankings of Indrayani Biotech

MSME (Udyam registered) Ministry of MSME
Category
Medium (2024-25)
Udyam number
UDYAM-TN-02-0023808

Contact details

Indrayani Biotech Limited's registered office is in Chennai, Tamil Nadu. Its website is indrayani.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    indrayani.com
  • Registered Address
    Block 1 Module No.33 3rd Floor SIDCO Electronic Complex Thiru VI Ka Industrial Estate G, Uindy, Chennai, Tamil Nadu, India – 600032
  • Industry
    Agriculture, Fertilizers & Soil Enhancers

To see the full contact details of Indrayani Biotech Limited, buy the company report.

Comprehensive company report
Indrayani Biotech Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Indrayani Biotech operates one associated brand: Indrayani Biotech. Each brand links to its own profile.

BrandDescriptionWebsite
Indrayani Biotech
Diversified crop nutrition and protection solutions are provided for farmers.indrayani.com

Business activity

The main business activities of Indrayani Biotech are manufacturing and accommodation and food service. In detail, this covers electrical equipment, general purpose and special purpose machinery & equipment, transport equipment and food and beverage services provided by hotels, restaurants, caterers, etc.. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC10Electrical equipment, General Purpose and Special purpose Machinery & equipment, Transport equipment
IAccommodation and Food ServiceI2Food and beverage services provided by hotels, restaurants, caterers, etc.

To see the full business activity and turnover split of Indrayani Biotech Limited, buy the company report.

Financials of Indrayani Biotech Limited

FY 2025-26 filings available

Indrayani Biotech Limited reported revenue of ₹137.83 Cr (up 5.8% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹138 Cr
+5.8% YoY
EBITDA
₹9.63 Cr
+50.9% YoY
Profit After Tax
₹2.16 Cr
+135.4% YoY
Net Worth
-
Total Assets
-
Total Debt
-

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue13813016616361.5721.0949.90
Revenue growth+5.8%-21.7%+2.0%+164.6%+191.9%-57.7%-
EBITDA9.636.3823.6616.826.78(9.05)2.77
EBITDA margin+7.0%+4.9%+14.2%+10.3%+11.0%-42.9%+5.6%
Profit before tax0.30(5.74)10.9712.324.45(11.21)0.81
Net profit2.16(6.10)6.369.244.45(7.10)0.81
Net profit margin+1.6%-4.7%+3.8%+5.7%+7.2%-33.7%+1.6%
EPS (₹)0.48(1.34)1.402.551.30(3.28)2.22
Balance sheet
Total assets-23718911943.3635.6244.58
Net worth-72.5267.2255.0924.1719.7230.83
Total debt-13711370.1918.8015.5413.74
Cash & bank-0.290.583.041.500.681.40
Net working capital-14799.7740.1110.884.7312.30
Cash flow
Cash from operations-(6.74)(30.35)16.194.110.265.96
Cash from investing-24.74(16.34)(47.39)(0.56)(0.70)(3.67)
Cash from financing-(18.30)44.2432.74(2.73)(0.28)(1.28)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue37.7137.7635.0135.9529.1050.5717.3230.81
Revenue growth (YoY)+29.6%-25.3%+102.1%+16.7%-7.7%+14.0%--
Other income1.590.880.831.801.062.780.000.30
EBITDA1.472.212.782.452.18(5.74)2.925.10
EBITDA margin+3.9%+5.9%+7.9%+6.8%+7.5%-11.4%+16.9%+16.6%
Depreciation1.101.131.011.300.86(1.72)1.462.79
Interest1.373.082.471.892.177.071.031.42
Profit before tax0.59(1.12)0.131.060.21(8.31)0.431.19
Tax0.05(2.08)0.030.150.050.210.08(0.02)
Net profit0.540.960.100.910.16(8.52)0.351.21
EPS (₹)0.060.240.030.090.03(1.88)0.050.13
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue21.9037.7762.3274.4857.9921.0149.90
Revenue growth-42.0%-39.4%-16.3%+28.4%+176.0%-57.9%-
EBITDA1.585.565.808.236.25(8.77)2.77
EBITDA margin+7.2%+14.7%+9.3%+11.1%+10.8%-41.7%+5.6%
Profit before tax1.200.663.015.094.24(10.88)0.81
Net profit0.701.461.465.574.24(6.77)0.81
Net profit margin+3.2%+3.9%+2.3%+7.5%+7.3%-32.2%+1.6%
EPS (₹)0.150.320.321.481.23(3.18)2.22
Balance sheet
Total assets-11711893.8640.9135.3844.58
Net worth-55.3454.5251.1524.1819.9530.83
Total debt-61.6663.4642.7116.7315.4313.74
Cash & bank-0.060.260.621.450.631.40
Net working capital-67.1664.4942.919.494.5812.30
Cash flow
Cash from operations-17.3526.098.333.470.525.96
Cash from investing-(1.34)(7.26)(14.09)0.59(0.56)(3.67)
Cash from financing-(16.22)(19.19)4.93(3.23)(0.73)(1.28)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.154.085.205.936.699.288.199.51
Revenue growth (YoY)-38.0%-56.0%-36.5%-37.6%-38.0%-41.3%--
Other income0.190.820.681.820.890.930.660.89
Total expenses3.263.884.545.975.947.566.868.07
EBITDA0.890.200.66(0.04)0.751.721.331.44
EBITDA margin+21.4%+4.9%+12.7%-0.7%+11.2%+18.5%+16.2%+15.1%
Depreciation0.120.180.140.170.150.060.320.32
Interest0.760.541.090.991.322.391.521.89
Profit before tax0.200.300.110.620.170.200.150.12
Tax0.050.280.030.160.04(0.91)0.040.03

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 08 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue37.7137.7635.0135.9529.1050.5717.3230.81
Revenue growth (YoY)+29.6%-25.3%+102.1%+16.7%-7.7%+14.0%--
Other income1.590.880.831.801.062.780.000.30
EBITDA1.472.212.782.452.18(5.74)2.925.10
EBITDA margin+3.9%+5.9%+7.9%+6.8%+7.5%-11.4%+16.9%+16.6%
Depreciation1.101.131.011.300.86(1.72)1.462.79
Interest1.373.082.471.892.177.071.031.42
Profit before tax0.59(1.12)0.131.060.21(8.31)0.431.19
Tax0.05(2.08)0.030.150.050.210.08(0.02)
Net profit0.540.960.100.910.16(8.52)0.351.21
EPS (₹)0.060.240.030.090.03(1.88)0.050.13
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue13813016616361.5721.0949.90
Revenue growth+5.8%-21.7%+2.0%+164.6%+191.9%-57.7%-
Other income4.573.131.214.490.220.270.20
Total expenses12812414314654.7930.1447.13
Employee cost0.0019.6923.0723.019.585.3910.81
EBITDA9.636.3823.6616.826.78(9.05)2.77
EBITDA margin+7.0%+4.9%+14.2%+10.3%+11.0%-42.9%+5.6%
Depreciation4.303.373.803.350.660.461.01
Interest9.6011.8810.105.641.891.971.15
Profit before tax0.30(5.74)10.9712.324.45(11.21)0.81
Tax(1.86)0.360.550.370.000.000.00
Net profit2.16(6.10)6.369.244.45(7.10)0.81
Net profit margin+1.6%-4.7%+3.8%+5.7%+7.2%-33.7%+1.6%
EPS (₹)0.48(1.34)1.402.551.30(3.28)2.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-45.5445.5443.4834.2334.233.64
Reserves & surplus-23.4917.5610.07(10.06)(14.51)(3.39)
Shareholders' funds (net worth)-72.5267.2255.0924.1719.7230.83
Minority interest-27.419.05(6.73)0.410.360.00
Secured loans-13510862.7517.8915.5413.05
Unsecured loans-1.644.867.440.910.000.69
Total debt-13711370.1918.8015.5413.74
Total liabilities-23718911943.3635.6244.58
Assets
Gross block-10210288.8658.1916.8518.38
Net block-57.6862.4257.4816.5115.3817.37
Capital work in progress-25.6720.3013.7413.2713.7213.59
Investments-0.250.220.220.000.010.01
Inventories-41.3442.3512.211.531.095.07
Sundry debtors-58.6939.5329.9714.104.777.04
Cash & bank balances-0.290.583.041.500.681.40
Loans & advances-77.6262.5232.301.782.625.68
Total current assets-17814577.5218.919.1619.19
Total current liabilities-30.8245.2137.418.034.436.89
Net working capital-14799.7740.1110.884.7312.30
Total assets-23718911943.3635.6244.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.583.041.500.681.400.39
Net cash from operating activities-(6.74)(30.35)16.194.110.265.96
Net cash from investing activities-24.74(16.34)(47.39)(0.56)(0.70)(3.67)
Net cash from financing activities-(18.30)44.2432.74(2.73)(0.28)(1.28)
Net change in cash-(0.29)(2.45)1.530.82(0.72)1.01
Closing cash-0.290.583.041.500.681.40
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+5.8%-21.7%+2.0%+164.6%+191.9%-57.7%-
EBITDA growth+50.9%-73.0%+40.7%+148.1%+174.9%-426.7%-
PBT growth+9998.0%--11.0%+176.9%+9998.0%-+9997.0%
Net income growth+135.4%-195.9%-31.2%+107.6%+162.7%-976.5%-
Revenue CAGR (3Y)-5.4%+28.4%+99.0%+48.4%---
EBITDA CAGR (3Y)-17.0%-2.0%-+82.4%---
Profitability & leverage
Net income margin+1.6%-4.7%+6.3%+7.3%+7.2%-53.2%+1.6%
Return on capital employed-+3.2%+13.8%+20.0%+14.3%0.0%+4.1%
Return on net worth--8.8%+18.2%+29.3%+16.5%0.0%+2.4%
Debt / equity-1.791.491.120.780.580.45
Long-term debt / equity-0.970.870.540.350.300.23
Interest cover180.11394.6850.8641.8730.88-20.7265.34
Efficiency & per share
Fixed asset turnover-1.281.752.221.641.202.71
Inventory turnover-3.116.0923.7247.006.859.84
Debtors turnover-2.654.787.396.533.577.09
EPS (₹)0.48(1.34)1.402.551.30(3.28)2.22
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0015.1613.8612.947.065.760.70
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue4.154.085.205.936.699.288.199.51
Revenue growth (YoY)-38.0%-56.0%-36.5%-37.6%-38.0%-41.3%--
Other income0.190.820.681.820.890.930.660.89
Total expenses3.263.884.545.975.947.566.868.07
EBITDA0.890.200.66(0.04)0.751.721.331.44
EBITDA margin+21.4%+4.9%+12.7%-0.7%+11.2%+18.5%+16.2%+15.1%
Depreciation0.120.180.140.170.150.060.320.32
Interest0.760.541.090.991.322.391.521.89
Profit before tax0.200.300.110.620.170.200.150.12
Tax0.050.280.030.160.04(0.91)0.040.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue21.9037.7762.3274.4857.9921.0149.90
Revenue growth-42.0%-39.4%-16.3%+28.4%+176.0%-57.9%-
Other income4.213.523.620.640.220.260.20
Total expenses20.3232.2156.5266.2551.7429.7847.13
Employee cost0.0012.8615.2317.108.485.2210.81
EBITDA1.585.565.808.236.25(8.77)2.77
EBITDA margin+7.2%+14.7%+9.3%+11.1%+10.8%-41.7%+5.6%
Depreciation0.641.021.450.930.340.401.01
Interest3.957.404.962.851.891.971.15
Profit before tax1.200.663.015.094.24(10.88)0.81
Tax0.50(0.80)1.550.020.000.000.00
Net profit0.701.461.465.574.24(6.77)0.81
Net profit margin+3.2%+3.9%+2.3%+7.5%+7.3%-32.2%+1.6%
EPS (₹)0.150.320.321.481.23(3.18)2.22
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital-45.5445.5443.4834.2334.233.64
Reserves & surplus-6.314.866.13(10.05)(14.28)(3.39)
Shareholders' funds (net worth)-55.3454.5251.1524.1819.9530.83
Secured loans-61.6658.6035.2716.7315.4313.05
Unsecured loans-0.004.867.440.000.000.69
Total debt-61.6663.4642.7116.7315.4313.74
Total liabilities-11711893.8640.9135.3844.58
Assets
Gross block-20.5325.8026.5017.0916.5318.38
Net block-16.6621.6623.8115.3315.1117.37
Capital work in progress-18.0918.0312.7213.2213.7213.59
Investments-9.619.567.990.190.190.01
Inventories-1.691.921.861.371.085.07
Sundry debtors-16.4617.6016.2312.884.777.04
Cash & bank balances-0.060.260.621.450.631.40
Loans & advances-62.4251.7230.622.312.565.68
Total current assets-80.6371.5049.3318.019.0419.19
Total current liabilities-13.477.016.428.524.466.89
Net working capital-67.1664.4942.919.494.5812.30
Total assets-11711893.8640.9135.3844.58
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash-0.260.621.450.631.400.39
Net cash from operating activities-17.3526.098.333.470.525.96
Net cash from investing activities-(1.34)(7.26)(14.09)0.59(0.56)(3.67)
Net cash from financing activities-(16.22)(19.19)4.93(3.23)(0.73)(1.28)
Net change in cash-(0.20)(0.36)(0.83)0.82(0.78)1.01
Closing cash-0.060.260.621.450.631.40
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth-42.0%-39.4%-16.3%+28.4%+176.0%-57.9%-
EBITDA growth-71.6%-4.1%-29.5%+31.7%+171.3%-416.6%-
PBT growth+81.8%-78.1%-40.9%+20.1%+9998.0%-+9998.0%
Net income growth-52.1%0.0%-73.8%+31.4%+162.6%-935.8%-
Revenue CAGR (3Y)-33.5%-13.3%+43.7%+14.3%---
EBITDA CAGR (3Y)-42.3%-3.8%-+43.8%-+307.1%-
Profitability & leverage
Net income margin+3.2%+3.9%+2.3%+6.8%+7.3%-51.8%+1.6%
Return on capital employed-+6.7%+7.2%+10.6%+14.2%0.0%+8.2%
Return on net worth-+2.5%+2.8%+12.5%+15.6%0.0%+4.8%
Debt / equity-1.141.000.790.730.570.48
Long-term debt / equity-0.300.330.300.340.300.25
Interest cover420.21163.00114.0239.0431.98-21.4865.34
Efficiency & per share
Fixed asset turnover-1.632.383.423.451.205.43
Inventory turnover-20.9332.9746.1247.346.8319.68
Debtors turnover-2.223.685.126.573.5614.18
EPS (₹)0.150.320.321.481.23(3.18)2.22
Dividend per share (₹)0.000.000.000.000.000.000.00
Book value per share (₹)0.0011.3911.0711.797.065.830.70

To see the full year-wise statements and ratios of Indrayani Biotech Limited, buy the company report.

Board of directors of Indrayani Biotech Limited

Indrayani Biotech has 6 current directors and 25 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Nangavaram Mahadevan Ranganathan
Also directs: Dindigul Farm Product Limited, Sip Industries Limited, Garudrik AI Private Limited
Director20 Aug 20188 Years 2 MonthsCurrent
Kannimangalam Subramanyan Vaidyanathan
Also directs: Qpro Design Consultants Private Limited
Director20 Aug 20188 Years 2 MonthsCurrent
Kasiraman Sayee Sundar
Also directs: Ibl Thiruvanamalai LLP, Ibl Laksha Hospitals LLP, Ibl Investments Limited and 4 more
Managing Director17 Feb 20188 Years 8 MonthsCurrent
Bokara Nagarajan Padmaja Priyadarshini
Also directs: Dindigul Farm Product Limited, Xchanging Solutions Limited, Homeplanguru Civil Consultants Private Limited
Director26 Mar 20215 Years 7 MonthsCurrent
Swaminathan Govindarajan
Also directs: Ibl Investments Limited, Hslprime Properties Private Limited, Sical Connect Limited
Whole-Time Director01 Aug 20206 Years 3 MonthsCurrent
Muthukrishnan RameshWhole-Time Director04 Jan 20215 Years 10 MonthsCurrent
View all directors

Shareholding

Shareholding for the quarter ended Mar 2026: promoters hold 33.30%, foreign institutional investors hold 0.00%, domestic institutional investors hold 3.10% and retail and other public shareholders hold 63.60%.

Promoters: 33.30%DII (Domestic Institutional): 3.10%Retail & Others: 63.60%
Mar 2026
QUARTER
33.30% Promoters
3.10% DII (Domestic Institutional)
63.60% Retail & Others
Promoter holding - history
Now 33.30% · Mar 2026High 33.30% · Jun 2025Low 33.30% · Jun 2025
32%32.8%33.5%34.3%35%Jun 2025Sep 2025Dec 2025Mar 2026Jun 2025: 33.30%Sep 2025: 33.30%Dec 2025: 33.30%Mar 2026: 33.30%33.30%33.30%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025
Promoters33.30%33.30%33.30%33.30%
Public66.70%66.70%66.70%66.70%

Charges & borrowings

Open charges
₹23.62 Cr
Satisfied charges
₹1.16 Cr
Breakdown by lending institutions
Others₹13.25 Cr
Axis Bank Limited₹10.00 Cr
Hdfc Bank Limited₹0.37 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
13 Mar 2026101271704Others₹2 CrOpen
26 Feb 2024100883173Hdfc Bank Limited₹37 LakhOpen
21 Jan 2023100668296Others₹7 CrOpen
08 Dec 2022100661361Others₹19 LakhOpen
16 Nov 2022100662838Others₹8.58 LakhOpen

To see the full charge records of Indrayani Biotech Limited, buy the company report.

Total charge records: 14 View all charges

Deals & funding

Indrayani Biotech Limited has 14 deals on record (14 market trades); the latest was in June 2026.

Total deals
14
Market trades
14

Deals on record (5 of 14)

WhenDealAmountParties
Jun 2024Market trade₹8.26 CrBuyer: Rajasthan Global Securities Private Limited , Topgain Finance Private Limited
Seller: Next Orbit Ventures, Sahastraa Advisors Private Limited , Topgain Finance Private Limited
Jun 2024Market trade₹1.58 CrBuyer: Sahastraa Advisors Private Limited
Jul 2023Market trade₹1.21 CrSeller: Bougainvillea Investments Private Limited
Aug 2022Market trade₹8.4 CrBuyer: India Equity Fund 1, Mittal Clothing Company, Multiplier Share and Stock Advisors Private Limited
Seller: Next Orbit Ventures, Multiplier Share and Stock Advisors Private Limited , an individual
May 2021Market trade₹9.9 LakhBuyer: Bougainvillea Investments Private Limited
Seller: Bougainvillea Investments Private Limited

To see the full deal history of Indrayani Biotech Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Indrayani Biotech Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Group structure & subsidiaries

Indrayani Biotech has 9 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

9
Subsidiary companies
Key subsidiaries
Company NameCINShares held
HSL Agri Solutions LimitedU01100TN2018PLC121939
Dindigul Farm Product Private LimitedU15200TZ2010PTC016407
Matrix Boilers Private LimitedU28131TN2006PTC060358
Ibl Investments LimitedU65990TN2022PLC152486
Hslprime Properties Private LimitedU70103TN2017PTC114104
Healthway India Private LimitedU74900TN2013PTC091433

To see the full group structure of Indrayani Biotech Limited, buy the company report.

Employees & EPFO

Indrayani Biotech Limited has a workforce of 445 employees on its EPFO records as of Apr 09, 2024, across 2 active EPFO establishments.

Employee count
445
Active EPFO establishments
2
Employee growth
9.61%

GST

Indrayani Biotech has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
33AAACI3911M1ZQTamil NaduActive04 Jun 2019
37AAACI3911M1ZIAndhra PradeshActive19 Aug 2023

To see the full GST registrations and return filing status of Indrayani Biotech Limited, buy the company report.

Recent activity

Indrayani Biotech Limited has 38 board changes on record since 1992: 23 appointments and 15 cessations. The latest: Lakshmiprabha Kasiraman ceased to be Director on 13 Nov 2025.

Filing
Indrayani Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Chennai.
Charges
A charge with Others of Rs. 2.00 Cr registered on 13 Mar 2026 with Charge ID 101271704 was modified on 17 Mar 2026.
Charges
A charge with Others amounted to Rs. 2.00 Cr with Charge ID 101271704 was registered on 13 Mar 2026.
Charges
A charge registered on 26 Apr 2022 via Charge ID 100576294 with Others was fully satisfied on 23 Dec 2025.
Charges
A charge registered on 26 Apr 2022 via Charge ID 100590098 with Others was fully satisfied on 23 Dec 2025.
Charges
A charge registered on 26 Apr 2022 via Charge ID 100590747 with Others was fully satisfied on 08 Dec 2025.
Ceased
Lakshmiprabha Kasiraman ceased to be Director.
AGM
Indrayani Biotech Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Appointed
Dhinakaran Rajagopal was appointed as CFO.
Charges
A charge with Others of Rs. 7.00 Cr registered on 21 Jan 2023 with Charge ID 100668296 was modified on 18 Feb 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.37 Cr with Charge ID 100883173 was registered on 26 Feb 2024.
Charges
A charge with Others amounted to Rs. 7.00 Cr with Charge ID 100668296 was registered on 21 Jan 2023.

52 earlier events are in the company report.

News

Frequently asked questions

Indrayani Biotech is an active public limited company based in Chennai, Tamil Nadu, India. The company works in fertilizers and soil enhancers, within the agriculture industry. It was incorporated on 09 March 1992 (34+ years old) and is registered under CIN L40100TN1992PLC129301. Listed on BSE: 526445.

Indrayani Biotech reported revenue of ₹137.83 Cr for FY 2025-26 (up 5.8% YoY) based on consolidated financials.

Indrayani Biotech has 6 current directors:

The latest financial statements of Indrayani Biotech on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 29 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Indrayani Biotech is 33AAACI3911M1ZQ, registered in Tamil Nadu. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 37AAACI3911M1ZI (Andhra Pradesh).

The CIN (Corporate Identification Number) of Indrayani Biotech is L40100TN1992PLC129301. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Indrayani Biotech is a listed company as per MCA records. Its shares are listed on BSE (code: 526445).

Indrayani Biotech has 26 court cases on record: 20 filed by the company and 6 filed against it. 5 are pending. Most are in the high courts.

Indrayani Biotech was incorporated on 09 March 1992, making it 34+ years old. It is registered with the Registrar of Companies, Chennai.

Indrayani Biotech has 14 deals on record (14 market trades); the latest was in June 2026.